MIXED ANXIETY AND DEPRESSION - DIAGNOSIS AND TREATMENT OPTIONS

Citation
D. Bakish et al., MIXED ANXIETY AND DEPRESSION - DIAGNOSIS AND TREATMENT OPTIONS, CNS DRUGS, 9(4), 1998, pp. 271-280
Citations number
69
Categorie Soggetti
Neurosciences,"Pharmacology & Pharmacy
Journal title
ISSN journal
11727047
Volume
9
Issue
4
Year of publication
1998
Pages
271 - 280
Database
ISI
SICI code
1172-7047(1998)9:4<271:MAAD-D>2.0.ZU;2-7
Abstract
Symptoms of anxiety and depression often appear together in patients, either as 2 discrete disorders, such as major depressive disorder and panic disorder, or as a combination of symptoms not meeting criteria f or specific disorders. The social, economic, occupational and medical costs of such comorbid anxiety and depression can be enormous, affecti ng both the individual and society, The clinician must be creative whe n treating patients with mixed anxiety and depressive symptoms; psycho pharmacological treatment can involve the use of a variety of mono-and polytherapies. Benzodiazepines can be effective in treating anxiety s ymptoms, but unwanted adverse effects limit their use to the short ter m. Tricyclic antidepressants, although proven to be effective in treat ing both anxiety and depressive symptoms, have numerous adverse effect s, making them a second-choice therapy. Traditional monoamine oxidase inhibitors have proven efficacy in atypical depression, and the newer reversible and selective inhibitors of monoamine oxidase-A may prove t o be very effective in treating both sets of symptoms. Of particular i mportance in the treatment of patients with anxiety and depressive sym ptoms are the selective serotonin (5-hydroxytryptamine; 5-MT) reuptake inhibitors, nefazodone and the azapirones (including buspirone).